Sarah Chapman, a 67-year-old retired audiologist and hockey umpire from Maidstone, Kent, spent years managing persistent, unexplained symptoms that doctors repeatedly attributed to aging and menopause before she received a diagnosis of blood cancer, according to regional news reports. Her case, highlighted by the charity Leukaemia UK during Blood Cancer Awareness Month, underscores the diagnostic challenges women face when non-specific systemic symptoms overlap with midlife endocrine changes.
The Progression of Unexplained Symptoms From 2011 Onward
Ms. Chapman’s health concerns began in 2011 when she experienced unusual and persistent fatigue. Despite maintaining a healthy diet and working as a regular blood donor, her haemoglobin levels dropped consistently too low for donation and failed to respond to iron supplements, as reported by outlets covering the case. Over subsequent months, her symptoms expanded to include diminished physical endurance, frequent illnesses, recurring chest infections, slow-healing wounds, night sweats, and skin issues. Various medical specialists evaluated her during this period, but she stated that many of her complaints were dismissed as standard consequences of aging and the menopausal transition. “I was referred to many different specialists and told that it was probably due to my age as I was around menopause, but I knew what I was capable of, and how active I was, and I felt deep down something was wrong,” Ms. Chapman recalled.
Diagnosis of Myelodysplastic Syndrome at Maidstone Hospital
The diagnostic trajectory shifted in 2013 when a new general practitioner re-examined Ms. Chapman’s blood test results and referred her to Maidstone Hospital. Specialists there diagnosed her with myelodysplastic syndrome (MDS), a disorder characterized by poorly formed blood cells produced in the bone marrow. Clinicians informed her at the time that the condition carried a strong statistical likelihood of progressing into acute leukemia within three to five years. True to that medical prognosis, exactly three years post-diagnosis, the condition advanced into acute myeloid leukaemia (AML), an aggressive form of blood cancer.
Treatment and Return to Competitive Sport
To combat the acute myeloid leukaemia, Ms. Chapman underwent intensive chemotherapy regimens followed by a stem cell transplant in 2016. The procedure utilized donor stem cells provided by her brother, Colin. Demonstrating a remarkable recovery, she returned to playing and umpiring field hockey just 10 months after completing the transplant procedure. “Hockey has been a huge part of my life and a huge factor in who I am,” she noted, expressing gratitude for her physical rehabilitation and ongoing return to active coaching and umpiring.
Implications for Primary Care and Blood Cancer Awareness
Fiona Hazell, chief executive of Leukaemia UK, emphasized that the lack of distinct initial indicators often leads to delayed identification. “Most of the signs and symptoms are not specific, so can often get mistaken for other illnesses or be explained away,” Ms. Hazell stated, noting that approximately 28 people receive a leukaemia diagnosis every day across the UK. Health advocates suggest that persistent low haemoglobin unresponsive to iron supplementation, recurring infections, and prolonged wound healing in middle-aged patients warrant comprehensive blood counts and timely referrals to hematology specialists rather than immediate attribution to menopause.
Keep reading